International Journal of
Reproductive Biomedicine
Sat, Sep 21, 2024
[Archive]
Volume 17, Issue 4 (April 2019 2019)
IJRM 2019, 17(4): 253-260 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hadadianpour S, Tavana S, Tavana A, Fallahian M. Immediate dilation of a tight or stenotic cervix by intra-procedural administration of hyoscine butylbromide: A clinical trial. IJRM 2019; 17 (4) :253-260
URL: http://ijrm.ir/article-1-1492-en.html
URL: http://ijrm.ir/article-1-1492-en.html
1- Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- University of Texas South West (UTSW), Dallas, Texas, USA ,Shahrzad.Tavana@utexas.edu
3- University of Texas Medical Branch (UTMB), Texas, USA
2- University of Texas South West (UTSW), Dallas, Texas, USA ,
3- University of Texas Medical Branch (UTMB), Texas, USA
Abstract: (2390 Views)
Background: Cervical dilation is indicated prior to performing various gynecological procedures. However, gynecologists are at times confronted with a stenotic or tight cervix, resistant to dilation. This can be problematic particularly when cervical ripening has not been attempted hours before the start of the procedure.
Objective: The objective of this study is to investigate the efficacy of administration of hyoscine butylbromide for cervical dilation for immediate dilation of the tight or stenotic cervix.
Materials and Methods: In this clinical trial study, a population of 40 women, aged 20-70 yr with stenotic cervix, evidenced by resistance to pass dilator #2 through their cervical canal were compared. Cervical patency was assessed 10 min following intracervical canal instillation of hyoscine butylbromide.
Results: Cervical width of 57.5% of patients became wider, as evidenced by passage of the number 4 Hegar dilator through the cervical canal without resistance. Independent T-tests did not reveal any statistically significant difference between the two groups based on their age. Fisher Exact test revealed a statistically significant difference between the two groups based on the prior route of delivery, with a more statistically significant response in patients who had vaginal deliveries.
Conclusion: Intra-cervical canal instillation of hyoscine butylbromide is effective in immediate dilation of the tight or stenotic cervix during intra-uterine procedures.
Objective: The objective of this study is to investigate the efficacy of administration of hyoscine butylbromide for cervical dilation for immediate dilation of the tight or stenotic cervix.
Materials and Methods: In this clinical trial study, a population of 40 women, aged 20-70 yr with stenotic cervix, evidenced by resistance to pass dilator #2 through their cervical canal were compared. Cervical patency was assessed 10 min following intracervical canal instillation of hyoscine butylbromide.
Results: Cervical width of 57.5% of patients became wider, as evidenced by passage of the number 4 Hegar dilator through the cervical canal without resistance. Independent T-tests did not reveal any statistically significant difference between the two groups based on their age. Fisher Exact test revealed a statistically significant difference between the two groups based on the prior route of delivery, with a more statistically significant response in patients who had vaginal deliveries.
Conclusion: Intra-cervical canal instillation of hyoscine butylbromide is effective in immediate dilation of the tight or stenotic cervix during intra-uterine procedures.
Type of Study: Original Article |
References
1. [1] Gelber S, Sciscione A. Mechanical methods of cervical ripening and labor induction. Clin Obstet Gynecol 2006; 49: 642-657. [DOI:10.1097/00003081-200609000-00022]
2. [2] Bradley LD. Complications in hysteroscopy: prevention, treatment, and legal risk. Curr Opin Obstet Gynecol 2002; 14: 409-415. [DOI:10.1097/00001703-200208000-00008]
3. [3] Mohammadian S, Tavana A, Tavana S, Mohammadian A, Fallahian M. Cervical priming by misoprostol before diagnostic dilatation and curettage: A randomized clinica trial. J Reprod Infertil 2015; 16: 162-166.
4. [4] Timmons B, Akins M, Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab 2010; 21: 353-361. [DOI:10.1016/j.tem.2010.01.011]
5. [5] Sirohiwal D, Dahiya K, De M. Efficacy of hyoscine-Nbutyl bromide (Buscopan) suppositories as a cervical spasmolytic agent in labour. Aust NZ J Obstet Gynaecol 2005; 45: 128-129. [DOI:10.1111/j.1479-828X.2005.00359.x]
6. [6] Hadadian S, Fallahian M. Assessing the efficacy of vaginal hyoscine butyl bromide on cervical ripening prior to intrauterine procedures: A double-blinded clinical trial. Int J Reprod Biomed 2016; 14: 709-712. [DOI:10.29252/ijrm.14.11.709]
7. [7] Samuels LA, Christie L, Roberts-Gittens B, Fletcher H, Frederick J. The effect of hyoscine butylbromide on the first stage of labour in term pregnancies. BJOG 2007; 114: 1542-1546. [DOI:10.1111/j.1471-0528.2007.01497.x]
8. [8] Hotwani J, Ainapure SS. Hyoscine Butylbromide suppositories. Indian Med Gaz 2000; 217-219.
9. [9] Qahtani NH, Hajeri FA. The effect of hyoscine butylbromide in shortening the first stage of labor: a double blind, randomized, controlled, clinical trial. Ther Clin Risk Manag 2011; 7: 495-500. [DOI:10.2147/TCRM.S16415]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
